Clinical Trial Update: Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the EpCAM-targeting imaging agent [99mTc]Tc(CO)3-(HE)3-Ec1 in adults with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• [99mTc]Tc(CO)3-(HE)3-Ec1

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Solid Tumor, Adult | Phase 1 | Status: COMPLETED